Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime

Journal of Oncology Pharmacy Practice

Volumn 15, Issue 4, 2009, Pages 217-222

  Ibrahim, Rami B ^a,b   Liu, Chin Y ^a,b   Cronin, Simon M ^a,b   Murphy, Bridgette C ^c   Cha, Raymond ^b   Swerdlow, Paul ^b   Avila, Tomoco ^a   Smith, Stephen T ^a   Lewis, Richard A ^d   Edwards, David J ^b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c BORGESS MEDICAL CENTER   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cefepime; Plasma exchange; Removal

Indexed keywords

CEFEPIME; CREATININE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BODY WEIGHT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DISPOSITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY ALLOGRAFT REJECTION; MALE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYELITIS; PLASMA VOLUME; PLASMAPHERESIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT INDICATION;

ADULT; AGED; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; PLASMA EXCHANGE; PLASMAPHERESIS;

EID: 75149183717     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155209103103     Document Type: Article

References (15)

1. Ibrahim RB, Liu C., Cronin SM et al. Drug removal by plasmapheresis: an evidence- based review. Pharmacotherapy 2007 ; 27 (11). 1529-1549.
2. Nye KJ, Shi YG, Andrews JM, Wise R. Pharmacokinetics and tissue penetration of cefepime. J Antimicrob Chemother 1989 ; 24 (1). 23-28.
3. Barbhaiya RH, Forgue ST, Gleason CR et al. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrob Agents Chemother 1992 ; 36 (3). 552-557.
4. Bozkurt F., Schollmeyer P., Keller E. Kinetics of ceftazidime during plasmapheresis. Eur J Clin Pharmacol 1987 ; 33 (2). 197-201.
5. Jain R., Danziger LH The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des 2004 ; 10 (25). 3045-3053.
6. Kintzel PE, Eastlund T., Calis KA Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher 2003 ; 18 (4). 194-205.
7. Barrons RW Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy 1997 ; 17 (6). 1220-1232.
8. Argov Z., Brenner T., Abramsky O. Ampicillin may aggravate clinical and experimental myasthenia gravis. Arch Neurol 1986 ; 43 (3). 255-256.
9. ORiordan J., Javed M., Doherty C., Hutchinson M. Worsening of myasthenia gravis on treatment with imipenem/cilastatin. J Neurol Neurosurg Psychiatry 1994 ; 57 (3). 383.
10. Thangkhiew I. Successful treatment with ceftazidime of a Pseudomonas fluorescens chest infection in a myasthenic patient. J Antimicrob Chemother 1986 ; 18 (3). 428-429.
11. Kieft H., Hoepelman AI, Knupp CA et al. Pharmacokinetics of cefepime in patients with the sepsis syndrome. J Antimicrob Chemother 1993 ; 32 (Suppl B): 117-122.
12. Malone RS, Fish DN, Abraham E., Teitelbaum I. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother 2001 ; 45 (11). 3148-3155. (Pubitemid 32988842)
13. Ezidiegwu C., Spektor Z., Nasr MR, Kelly KC, Rosales LG A case report on the role of plasma exchange in the management of a massive amlodipine besylate intoxication. Ther Apher Dial 2008 ; 12 (2). 180-184.
14. Maynor LM, Carl DE, Matzke GR et al. An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis. Pharmacotherapy 2008 ; 28 (8). 977-983.
15. Barbhaiya RH, Knupp CA, Pfeffer M., Zaccardelli D. et al. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1992 ; 36: 1387-1391.